Cancer Research UK, Hummingbird join forces on anti-HER3 antibody drug
If successful, HMBD-001 could be used in the treatment of multiple cancers and be effective against drug resistant cancers.
Read More
Tag: anti-HER3
- European life sciences coalition launched to boost investment ecosystem
- 99mtc‑maraciclatide granted fast track status for ILD imaging
- Bioxytran reports rapid viral clearance in phase 2 trial
- Thx Pharma and Biocodex sign rare disease licensing deal
- AstraZeneca bladder cancer therapy wins NICE backing
